Modification of Promyelocytic Leukemia Zinc Finger Protein (PLZF) by SUMO-1 Conjugation Regulates its Transcriptional Repressor Activity

Soo Im Kang, Woo Jung Chang, Ssang Goo Cho, Ick Young Kim

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Promyelocytic leukemia zinc finger (PLZF) protein is a sequence-specific DNA-binding protein that represses the transcriptional activity of target genes such as those for cyclin A and the interleukin-3 receptor α chain. The PLZF gene becomes fused to the retinoic acid receptor α gene as a result of the t(11, 17)(q23;q21) chromosomal translocation that is associated with acute promyelocytic leukemia. We now show that endogenous PLZF in human promyelocytic leukemia HL-60 cells is modified by conjugation with SUMO-1 (small ubiquitin-related modifier-1) and that PLZF colocalizes with SUMO-1 in the nucleus of transfected human embryonic kidney 293T cells. Site-directed mutagenesis identified lysine 242 in the RD2 domain of human PLZF as the sumoylation site. A luciferase reporter gene assay suggested that SUMO-1 modification of this residue is required for transcriptional repression by PLZF, and an electrophoretic mobility shift assay showed that this modification increases the DNA binding activity of PLZF. PLZF-mediated regulation of the cell cycle and transcriptional repression of the cyclin A2 gene were also dependent on sumoylation of PLZF on lysine 242. These results demonstrate that PLZF is modified by SUMO-1 conjugation and that this modification regulates the biological functions of PLZF.

Original languageEnglish
Pages (from-to)51479-51483
Number of pages5
JournalJournal of Biological Chemistry
Volume278
Issue number51
DOIs
Publication statusPublished - 2003 Dec 19

Fingerprint

Small Ubiquitin-Related Modifier Proteins
Zinc Fingers
Zinc
Leukemia
Ubiquitin
Proteins
Genes
Sumoylation
Lysine
Assays
Cyclin A2
Interleukin-3 Receptors
Cyclin A
Electrophoretic mobility
Genetic Translocation
Mutagenesis
Acute Promyelocytic Leukemia
Retinoic Acid Receptors
HEK293 Cells
HL-60 Cells

ASJC Scopus subject areas

  • Biochemistry

Cite this

Modification of Promyelocytic Leukemia Zinc Finger Protein (PLZF) by SUMO-1 Conjugation Regulates its Transcriptional Repressor Activity. / Kang, Soo Im; Chang, Woo Jung; Cho, Ssang Goo; Kim, Ick Young.

In: Journal of Biological Chemistry, Vol. 278, No. 51, 19.12.2003, p. 51479-51483.

Research output: Contribution to journalArticle

@article{e6d0af76bf2749bbb816b9121be900c1,
title = "Modification of Promyelocytic Leukemia Zinc Finger Protein (PLZF) by SUMO-1 Conjugation Regulates its Transcriptional Repressor Activity",
abstract = "Promyelocytic leukemia zinc finger (PLZF) protein is a sequence-specific DNA-binding protein that represses the transcriptional activity of target genes such as those for cyclin A and the interleukin-3 receptor α chain. The PLZF gene becomes fused to the retinoic acid receptor α gene as a result of the t(11, 17)(q23;q21) chromosomal translocation that is associated with acute promyelocytic leukemia. We now show that endogenous PLZF in human promyelocytic leukemia HL-60 cells is modified by conjugation with SUMO-1 (small ubiquitin-related modifier-1) and that PLZF colocalizes with SUMO-1 in the nucleus of transfected human embryonic kidney 293T cells. Site-directed mutagenesis identified lysine 242 in the RD2 domain of human PLZF as the sumoylation site. A luciferase reporter gene assay suggested that SUMO-1 modification of this residue is required for transcriptional repression by PLZF, and an electrophoretic mobility shift assay showed that this modification increases the DNA binding activity of PLZF. PLZF-mediated regulation of the cell cycle and transcriptional repression of the cyclin A2 gene were also dependent on sumoylation of PLZF on lysine 242. These results demonstrate that PLZF is modified by SUMO-1 conjugation and that this modification regulates the biological functions of PLZF.",
author = "Kang, {Soo Im} and Chang, {Woo Jung} and Cho, {Ssang Goo} and Kim, {Ick Young}",
year = "2003",
month = "12",
day = "19",
doi = "10.1074/jbc.M309237200",
language = "English",
volume = "278",
pages = "51479--51483",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "51",

}

TY - JOUR

T1 - Modification of Promyelocytic Leukemia Zinc Finger Protein (PLZF) by SUMO-1 Conjugation Regulates its Transcriptional Repressor Activity

AU - Kang, Soo Im

AU - Chang, Woo Jung

AU - Cho, Ssang Goo

AU - Kim, Ick Young

PY - 2003/12/19

Y1 - 2003/12/19

N2 - Promyelocytic leukemia zinc finger (PLZF) protein is a sequence-specific DNA-binding protein that represses the transcriptional activity of target genes such as those for cyclin A and the interleukin-3 receptor α chain. The PLZF gene becomes fused to the retinoic acid receptor α gene as a result of the t(11, 17)(q23;q21) chromosomal translocation that is associated with acute promyelocytic leukemia. We now show that endogenous PLZF in human promyelocytic leukemia HL-60 cells is modified by conjugation with SUMO-1 (small ubiquitin-related modifier-1) and that PLZF colocalizes with SUMO-1 in the nucleus of transfected human embryonic kidney 293T cells. Site-directed mutagenesis identified lysine 242 in the RD2 domain of human PLZF as the sumoylation site. A luciferase reporter gene assay suggested that SUMO-1 modification of this residue is required for transcriptional repression by PLZF, and an electrophoretic mobility shift assay showed that this modification increases the DNA binding activity of PLZF. PLZF-mediated regulation of the cell cycle and transcriptional repression of the cyclin A2 gene were also dependent on sumoylation of PLZF on lysine 242. These results demonstrate that PLZF is modified by SUMO-1 conjugation and that this modification regulates the biological functions of PLZF.

AB - Promyelocytic leukemia zinc finger (PLZF) protein is a sequence-specific DNA-binding protein that represses the transcriptional activity of target genes such as those for cyclin A and the interleukin-3 receptor α chain. The PLZF gene becomes fused to the retinoic acid receptor α gene as a result of the t(11, 17)(q23;q21) chromosomal translocation that is associated with acute promyelocytic leukemia. We now show that endogenous PLZF in human promyelocytic leukemia HL-60 cells is modified by conjugation with SUMO-1 (small ubiquitin-related modifier-1) and that PLZF colocalizes with SUMO-1 in the nucleus of transfected human embryonic kidney 293T cells. Site-directed mutagenesis identified lysine 242 in the RD2 domain of human PLZF as the sumoylation site. A luciferase reporter gene assay suggested that SUMO-1 modification of this residue is required for transcriptional repression by PLZF, and an electrophoretic mobility shift assay showed that this modification increases the DNA binding activity of PLZF. PLZF-mediated regulation of the cell cycle and transcriptional repression of the cyclin A2 gene were also dependent on sumoylation of PLZF on lysine 242. These results demonstrate that PLZF is modified by SUMO-1 conjugation and that this modification regulates the biological functions of PLZF.

UR - http://www.scopus.com/inward/record.url?scp=0347065343&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347065343&partnerID=8YFLogxK

U2 - 10.1074/jbc.M309237200

DO - 10.1074/jbc.M309237200

M3 - Article

C2 - 14527952

AN - SCOPUS:0347065343

VL - 278

SP - 51479

EP - 51483

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 51

ER -